COOPER COMPANIES, INC. (COO) Stock
6 members of Congress disclosed 10 trades in COO since 2014: 6 purchases and 4 sales, most recently Gilbert Cisneros (purchase, Jun 5, 2026). 5 of the hedge funds AlphaScala tracks reported COO in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Citadel's at $277.69M. Company insiders reported 5 open-market buys and 0 sales on SEC Form 4 in the 90 days to Oct 21, 2026.
Which members of Congress traded COOPER COMPANIES, INC. (COO)?
Most recent: Gilbert Cisneros (purchase, Jun 5, 2026); records start Oct 22, 2014.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Gil Cisneros D-CA · House | 2026-06-05 | purchase | $1k – $15k |
| Gil Cisneros D-CA · House | 2026-05-29 | purchase | $1k – $15k |
| Gil Cisneros D-CA · House | 2025-12-10 | purchase | $1k – $15k |
| Rob Bresnahan R-PA · House | 2025-05-15 | sale | $1k – $15k |
| Susie Lee D-NV · House | 2020-02-25 | sale | $1k – $15k |
| Susie Lee D-NV · House | 2019-03-20 | purchase | $1k – $15k |
| Tom MacArthur R-NJ · House | 2018-06-07 | purchase | $15k |
| Tom Suozzi D-NY · House | 2017-01-05 | sale | $15k – $50k |
From STOCK Act periodic transaction reports. House filings as of Oct 20, 2026.
See all COO political trades →Which hedge funds own COO?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Citadel Ken Griffin | 3.87M | $277.69M | +1911% |
| Millennium Management Israel Englander | 505K | $36.23M | +369% |
| Marshall Wace | 256K | $18.35M | NEW |
| Bridgewater Associates Ray Dalio | 51K | $3.67M | +737% |
| D.E. Shaw David Shaw | 25K | $1.79M | NEW |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are COOPER COMPANIES, INC. insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Sep 16, 26 | Kurzius Lawrence Erik | Director | BUY | 10.0K | $549K |
| Sep 14, 26 | Kurzius Lawrence Erik | Director | BUY | 10.0K | $539K |
| Sep 14, 26 | Rosebrough Walter M Jr | Director | BUY | 3.0K | $163K |
| Sep 11, 26 | Rosebrough Walter M Jr | Director | BUY | 7.0K | $379K |
| Sep 11, 26 | Keel Paul A | Director | BUY | 4.7K | $250K |
SEC Form 4 filings as of Oct 21, 2026
See cluster-buy signals across all tickers →COO price chart
Powered by TradingViewWhat does COOPER COMPANIES, INC. do?
The Cooper Companies, Inc. is a global medical device company operating through two primary segments: CooperVision and CooperSurgical. CooperVision specializes in vision care, offering a comprehensive portfolio of contact lenses including spherical, multifocal, toric, and specialty lenses under brands such as Proclear, Biofinity, MyDay, and Clariti. It serves contact lens wearers worldwide with high-quality products and practitioner support, maintaining a significant presence in the contact lens market. CooperSurgical focuses on reproductive health, fertility, and women's care, providing a broad range of medical devices that cover the entire IVF cycle, along with products like Paragard, the only hormone-free IUD available in the US. The company advances health outcomes for women, babies, and families through its diversified offerings in medical devices, fertility, and genomics. Founded in 1958 and headquartered in San Ramon, California, The Cooper Companies, Inc. plays a key role in the healthcare sector, particularly in eyecare and reproductive medicine.